haya therapeutics
Series Ahaya therapeutics raised €58M in a Series A round in May 2025. The company is based in Lausanne, Switzerland. Investors in the round: +ND Capital, 4see Ventures, Alexandria Venture Investments and 9 others. Data as of Nov 2026.
Amount raised
€58M
€57,537,399
Native amount
65,000,000 USD
Stage
Series A
series a
Investors
12
Provenance & confidence
High confidenceAmount
65,000,000 USD
ECB-at-date → €58M · rate 1.1297 on 2025-05-08
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
12 named+ND Capital4see VenturesAlexandria Venture InvestmentsApollo Health VenturesAthos CapitalBernina BioInvestEarlybird Venture CapitalEli lilly and companyLifeLink VenturesLongview VenturesSchroders CapitalSofinnova Partners
Date
May 2025
Round type
series a
Amount (EUR)
€58M